Preclinical Characterization of MIN-301, a Neuregulin-1 Fragment, as a Potential Disease-Modifying Therapy for Parkinson's Disease

被引：0

作者：

Noel, Nadine ^{[1
]}

Werner, Sandra ^{[1
]}

Lowe, David ^{[1
]}

Detke, Michael ^{[1
]}

Luthringer, Remy ^{[1
]}

机构：

[1] Indiana Univ, Carmel, IN USA

来源：

NEUROPSYCHOPHARMACOLOGY | 2015年 / 40卷

关键词：

Parkinson's disease; Neuregulin; 6-OHDA; MPTP;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

W138

引用

页码：S529 / S530

页数：2

共 50 条

[21] A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease [J].

McGhee, David J. M. ;

Ritchie, Craig W. ;

Zajicek, John P. ;

Counsell, Carl E. .

BMC NEUROLOGY, 2016, 16

[22] Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy [J].

Olanow, CW ;

Jankovic, J .

MOVEMENT DISORDERS, 2005, 20 :S3-S10

[23] An optimized Nurr1 agonist provides disease-modifying effects in Parkinson's disease models [J].

Kim, Woori ;

Tripathi, Mohit ;

Kim, Chunhyung ;

Vardhineni, Satyapavan ;

Cha, Young ;

Kandi, Shamseer Kulangara ;

Feitosa, Melissa ;

Kholiya, Rohit ;

Sah, Eric ;

Thakur, Anuj ;

Kim, Yehan ;

Ko, Sanghyeok ;

Bhatia, Kaiya ;

Manohar, Sunny ;

Kong, Young-Bin ;

Sindhu, Gagandeep ;

Kim, Yoon-Seong ;

Cohen, Bruce ;

Rawat, Diwan S. S. ;

Kim, Kwang-Soo .

NATURE COMMUNICATIONS, 2023, 14 (01)

[24] Targeting microglial NLRP3 in the SNc region as a promising disease-modifying therapy for Parkinson's disease [J].

Qiao, Chen ;

Dang, Tao ;

Zhou, Yan ;

Zhou, Yuan-Zhang ;

Zhao, Rong ;

Wang, Min .

BRAIN AND BEHAVIOR, 2022, 12 (11)

[25] A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer’s disease and Parkinson’s disease [J].

David J. M. McGhee ;

Craig W. Ritchie ;

John P. Zajicek ;

Carl E. Counsell .

BMC Neurology, 16

[26] Endpoints and Analyses to Discern Disease-Modifying Drug Effects in Early Parkinson’s Disease [J].

Venkatesh Atul Bhattaram ;

Ohidul Siddiqui ;

Leonard P. Kapcala ;

Jogarao V. S. Gobburu .

The AAPS Journal, 2009, 11 :456-464

[27] Endpoints and Analyses to Discern Disease-Modifying Drug Effects in Early Parkinson's Disease [J].

Bhattaram, Venkatesh Atul ;

Siddiqui, Ohidul ;

Kapcala, Leonard P. ;

Gobburu, Jogarao V. S. .

AAPS JOURNAL, 2009, 11 (03) :456-464

[28] Disease-modifying treatment of Parkinson's disease by phytochemicals: targeting multiple pathogenic factors [J].

Naoi, Makoto ;

Maruyama, Wakako ;

Shamoto-Nagai, Masayo .

JOURNAL OF NEURAL TRANSMISSION, 2022, 129 (5-6) :737-753

[29] Disease-modifying treatment of Parkinson’s disease by phytochemicals: targeting multiple pathogenic factors [J].

Makoto Naoi ;

Wakako Maruyama ;

Masayo Shamoto-Nagai .

Journal of Neural Transmission, 2022, 129 :737-753

[30] Hot Topic: Epigenetics in Parkinson's Disease: A New Frontier for Disease-Modifying Therapies [J].

Portley, Makayla K. ;

Scholz, Sonja W. .

MOVEMENT DISORDERS, 2021, 36 (04) :862-862

← 1 2 3 4 5 →